Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Lurasidone 40 mg Tablet Relative to Latuda Under Fed Conditions in Healthy Thai Volunteers
TCTR20210902010Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lurasidone (2 arms), sponsored by Bio-innova. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
lurasidone
Beyond the preview
Go deeper on TCTR20210902010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210902010.